|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 409/06 | |
| A61K 31/4178 | |||
| A61P 31/10 |
| (11) | Number of the document | 2964641 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13736983.1 |
| Date of filing the European patent application | 2013-06-24 | |
| (97) | Date of publication of the European application | 2016-01-13 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2013/067952 |
| Date | 2013-06-24 |
| (87) | Number | WO 2014/136282 |
| Date | 2014-09-12 |
| (30) | Number | Date | Country code |
| 2013046593 | 2013-03-08 | JP |
| (72) |
MASUDA, Takaaki, JP
MIYATA, Yoshiyuki, JP
KANEDA, Hideo, JP
|
| (73) |
Pola Pharma Inc.,
8-9-5, Nishi-gotanda, Shinagawa-ku Tokyo 141-0031,
JP
Nihon Nohyaku Co., Ltd., 19-8, Kyobashi 1-chome Chuo-ku, Tokyo 104-8386, JP |
| (54) | CRYSTALLINE FORM HAVING SPECIFIC CRYSTAL HABIT AND PHARMACEUTICAL COMPOSITION CONTAINING THIS CRYSTALLINE FORM AS ACTIVE INGREDIENT |
| CRYSTALLINE FORM HAVING SPECIFIC CRYSTAL HABIT AND PHARMACEUTICAL COMPOSITION CONTAINING THIS CRYSTALLINE FORM AS ACTIVE INGREDIENT |